Advanced imaging, navigational guidance, radiotherapy combine to provide superior outcomes
In advanced neurosurgical care, few concepts are as important as access — access to the most comprehensive array of therapeutic options, access to the most experienced and technically adept clinicians, …
Gastrointestinal motility disorders, GERD and inflammatory bowel diseases have seen a significant rise in recent years, now affecting more than 30 percent of the adult U.S. population. To address this growing and increasingly complex patient population, the Cooper Digestive Health …
Growing evidence of the benefit of a multidisciplinary approach in the management of chronic and refractory headaches has led the Cooper Neurological Institute to establish a dedicated Headache Program under the direction of Cooper neurologist, Mitra Assadi, MD.…
Pelvic organ prolapse and urinary incontinence affect over 10 million women annually. Medical management remains the first line of treatment for many women. Non-surgical treatment options now include: pharmacologic therapy, lifestyle and behavioral changes, Kegel exercises, biofeedback with functional electrical …
Diagnosis of pediatric gastrointestinal disorders such as celiac disease, inflammatory bowel disease, and eosinophilic esophagitis requires a collaborative, patient-family centered approach. “Cooper has an excellent panel of pediatric sub-specialists in gastroenterology, anesthesiology, and radiology. We bring families through the system …
More than 300 civic, business and community leaders from around the state were present as officials from Rowan University and Cooper University Hospital broke ground for the Cooper Medical School of Rowan University on October 27. Honored guests for the …
It is estimated over 650,000 people in the United States currently have implanted cardiac devices (ICD’s) designed for defibrillation. Cooper University Hospital has recently become one of the first U.S. centers to participate in a ground-breaking clinical trial examining the …
Date/Times: Friday, May 20, 2011 – 7:30 AM – 2:45 PM
Location: Seaview, A Dolce Hotel, Galloway, NJ
Registration Fee: $75.00
The Pain Management Center at Cooper has expanded the use of chemical neurolytic (neuroablative) blocks to produce analgesia lasting 6 to 12 months in patients with severe pain due to intercostal …